Drs. Jeffrey Geske and Paul Friedman talk about the evolving panorama of therapies from therapy of hypertrophic cardiomyopathy. The dialogue consists of novel therapies (myosin inhibitors), the evolving position of septal discount remedy, and exploring unanswered questions.
Topics Discussed:
• Hypertrophic Cardiomyopathy
• Myosin Inhibitors
• Septal Reduction Therapy
